NARNATUMAB
UNII R42YK40U9M

Substance Identification & Data

This profile provides standardized clinical and technical data for Narnatumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R42YK40U9M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1188275-92-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R42YK40U9M

CAS Registry Number

1188275-92-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NARNATUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C91382

National Cancer Institute reference terminology for clinical and research data.

INN ID

9447

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-81

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Narnatumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NARNATUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN CELL SURFACE RECEPTOR RON) (HUMAN MONOCLONAL IMC-RON8 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMC-RON8 LIGHT CHAIN, DIMER

NARNATUMAB [INN]

NARNATUMAB [USAN]

NARNATUMAB [WHO-DD]